If AFG experiences significant adverse development in these areas, it could lead to earnings volatility, erosion of capital, and a potential downgrade in financial strength ratings. This situation ...
CVS director Mike Mahoney, whose day job is CEO of Boston Scientific, bought 30,000 shares of the healthcare company.